scholarly article | Q13442814 |
P50 | author | Raj R. Makkar | Q112157933 |
P2093 | author name string | Ke Cheng | |
Eduardo Marbán | |||
Eleni Tseliou | |||
Konstantinos Malliaras | |||
Baiming Sun | |||
Mohammad A Aminzadeh | |||
P2860 | cites work | Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy | Q39864941 |
Exosomes as critical agents of cardiac regeneration triggered by cell therapy. | Q40477633 | ||
Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel | Q42086615 | ||
Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice | Q42702321 | ||
Adenylyl cyclase increases survival in cardiomyopathy | Q43984501 | ||
Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. | Q45264888 | ||
Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains | Q46052807 | ||
Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction | Q46259595 | ||
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. | Q54465293 | ||
Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix | Q83582604 | ||
??? | Q28267062 | ||
A call for transparent reporting to optimize the predictive value of preclinical research | Q24289327 | ||
Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling | Q28213257 | ||
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload | Q33559670 | ||
Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction | Q33911038 | ||
c-kit+ cells minimally contribute cardiomyocytes to the heart | Q34021586 | ||
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 | ||
Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion | Q35068527 | ||
Cardiac cell therapy: where we've been, where we are, and where we should be headed | Q35144550 | ||
Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells | Q35666637 | ||
Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction | Q35714009 | ||
Differential PKC-dependent and -independent PKD activation by G protein α subunits of the Gq family: selective stimulation of PKD Ser⁷⁴⁸ autophosphorylation by Gαq. | Q35778013 | ||
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure | Q36286936 | ||
Transgenic Galphaq overexpression induces cardiac contractile failure in mice | Q36302328 | ||
Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both? | Q36315410 | ||
Nrf2: a potential molecular target for cancer chemoprevention by natural compounds | Q36399767 | ||
Secreted proteins as a fundamental source for biomarker discovery | Q36452973 | ||
Requirement of protein kinase D1 for pathological cardiac remodeling | Q36498485 | ||
Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. | Q36602112 | ||
Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression | Q36699619 | ||
Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen | Q37241022 | ||
Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. | Q37276044 | ||
Biomarkers of oxidative stress in heart failure | Q37561794 | ||
microRNA: a master regulator of cellular processes for bioengineering systems | Q37736481 | ||
Gq protein-induced apoptosis is mediated by AKT kinase inhibition that leads to protein kinase C-induced c-Jun N-terminal kinase activation | Q38264143 | ||
Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart | Q39142718 | ||
P433 | issue | 12 | |
P304 | page(s) | 751-762 | |
P577 | publication date | 2014-05-27 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy | |
P478 | volume | 36 |
Q91442462 | A mechanistic roadmap for the clinical application of cardiac cell therapies |
Q94603780 | Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series |
Q98226269 | COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention |
Q36957018 | Cadaveric cardiosphere-derived cells can maintain regenerative capacity and improve the heart function of cardiomyopathy |
Q48024280 | Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats. |
Q39310120 | Cardiac stem cells: translation to human studies. |
Q36169471 | Cardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment |
Q40286144 | Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation |
Q58478037 | Cardiosphere-derived cells suppress allogeneic lymphocytes by production of PGE2 acting via the EP4 receptor |
Q38859871 | Cellular Therapy for Heart Failure. |
Q33920152 | Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiation |
Q38737886 | Development and regulation of exosome-based therapy products |
Q90821706 | Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice |
Q34046358 | Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment |
Q55002268 | Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. |
Q96303273 | Extracellular Vesicles as Therapeutic Agents for Cardiac Fibrosis |
Q36121826 | Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles |
Q47104850 | Harnessing the heart's resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents. |
Q90473072 | Infant cardiosphere-derived cells exhibit non-durable heart protection in dilated cardiomyopathy rats |
Q47131574 | Integrin β-3 is required for the attachment, retention and therapeutic benefits of human cardiospheres in myocardial infarction |
Q41247871 | Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy. |
Q35597418 | Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction |
Q36006640 | Intravenous Cardiac Stem Cell-Derived Exosomes Ameliorate Cardiac Dysfunction in Doxorubicin Induced Dilated Cardiomyopathy |
Q39412555 | Is Cardioprotection Dead? |
Q36040528 | Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction |
Q90400720 | Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation |
Q89587258 | Microenvironment in Cardiac Tumor Development: What Lies Beyond the Event Horizon? |
Q55365025 | Molecular signature of progenitor cells isolated from young and adult human hearts. |
Q28085334 | Multipotent stem cells of the heart-do they have therapeutic promise? |
Q38986995 | Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research |
Q57029337 | Reverse electrical remodeling in rats with heart failure and preserved ejection fraction |
Q55071721 | Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles. |
Q50094811 | Stem cell therapy: from translational hurdles to new frontiers |
Q46302230 | The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy |
Q41512469 | Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension |
Q26774565 | Translational research of adult stem cell therapy |
Q28265872 | Using exosomes, naturally-equipped nanocarriers, for drug delivery |
Q27335541 | Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology |